Risk of Hypoglycemia Associated With Concomitant Use of Insulin Secretagogues and ACE Inhibitors in Adults With Type 2 Diabetes: A Systematic Review

Documenti analoghi

• Risk of Opioid Overdose Associated with Concomitant Use of Methadone and Statins
  di: Cheng Chen, et al.
  Pubblicazione: (2024)
• Concomitant Use of Oral Anticoagulants With Oral Dipeptidyl Peptidase‐4 Inhibitors and Serious Bleeding Events
  di: Thanh Phuong Pham Nguyen, et al.
  Pubblicazione: (2024)
• Concomitant 5‐Aminosalicylic Acid Does Not Affect the Efficacy of Janus Kinase Inhibitors in Ulcerative Colitis
  di: Antonio Tursi, et al.
  Pubblicazione: (2026)
• Risk versus Benefit of Tyrosine Kinase Inhibitors for Hepatocellular Carcinoma: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
  di: Tania Payo‐Serafín, et al.
  Pubblicazione: (2024)
• A Randomized Crossover Trial of Mixed Meal Tolerance Test Response in People with Type 1 Diabetes on Insulin Pump Therapy and YG1699 or Dapagliflozin
  di: Pablo Lapuerta, et al.
  Pubblicazione: (2024)